Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. - Wikidata - awgldk - TriplyDB

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

http://www.wikidata.org/entity/Q44954147

about

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders.Immunotherapy in Peripheral Neuropathies Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.Intravenous immunoglobulin in the treatment of neurologic disorders.Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.Comparisons in fluctuation of muscle strength and function in patients with immune-mediated neuropathy treated with intravenous versus subcutaneous immunoglobulin.Subcutaneous immunoglobulin for treatment of multifocal motor neuropathy.Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients.

P2860

Q26745685-5B552D71-B5B2-420E-A5DF-0607D0D5012D Q35780802-64C0DE4E-9685-4346-AB88-6E43905DC2BB Q36484418-87589BB3-CA7C-49C6-8AF0-29BA54605123 Q36737563-BA8DD666-B4E1-470A-BAFC-B6291DA00F56 Q37125900-B7E565F6-4263-4DEE-963D-B30CBBA473A3 Q38495457-FA1F9387-273A-44EF-AF26-C079F9A90BB7 Q38711142-44C92A46-06B6-485E-BB34-506A91526CFB Q39370917-E53A7356-7369-4475-A188-FB9D2EE28171 Q39468698-3A32544F-E667-4510-BCA9-B67EAC19E2EA Q39604919-84742D18-BB08-4EA4-8CDF-FB61B948D2A9 Q50205992-46E3D7E2-E619-45BA-81AE-0AC1C47D850C Q51134410-4488BA73-487D-4D9F-97DD-34664836EA10 Q51246055-3548E85B-B775-445B-AD77-67D0786F3C37 Q51649208-8E04F743-FE0C-4EAC-B145-F55D9A4542D3 Q53647790-1D459A24-8EA5-4B70-96D2-C13D9E52E4BF

P2860

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

http://www.wikidata.org/entity/Q44954147

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@en

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@nl

type

label

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@en

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@nl

prefLabel

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@en

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@nl

P1433

Q44954147-0B9CF654-D026-4A78-BA1F-5F0A33ECD45B

P1476

Q44954147-37DD4CB0-2E32-4BCB-AC4C-90D7CF0349E8

P2093

Q44954147-0CD22FE6-4D28-413C-9302-5558AEAB0DFC

Q44954147-156F88D0-261F-4EEF-8EA6-3AB943755438

Q44954147-2C2F1506-6253-46EB-BEE3-56CF7D102387

Q44954147-5BA139C1-89FD-4D43-BE85-0ED4582BBBF6

Q44954147-5C72E061-F79C-451E-83D6-561DFC240B5C

Q44954147-5FC34C53-FBB2-4DE1-A7EC-D2DFAF6E72C9

Q44954147-602C55BF-8720-4184-A8FF-5541A407256B

Q44954147-83D88834-CE2C-45A2-BF98-83C987216AB8

Q44954147-95236BC5-6AFD-4839-8275-C2F5629D46CF

Q44954147-9850E368-FF72-4BBE-8152-58BFE47C252C

P2860

Q44954147-17AA3098-DE3E-403B-AF30-E67FCA011EAC

Q44954147-1C0BF9D8-AEEB-4858-8705-AFB73B1D2927

Q44954147-58EDAA89-CB27-4E3E-A510-4C234A39090D

Q44954147-65568BE8-1E0B-4865-9DFA-7CE1F8A62FFD

Q44954147-9D0D0AE1-9D64-4BE8-8ACF-D427CEF940FF

Q44954147-B4D243F8-5028-48A2-8CFC-B593C180DDEA

Q44954147-DA048E6F-08A6-4522-8DA0-C1187BB1D6A1

P2888

Q44954147-BFF20B4B-8E2F-45FF-BA21-3B6C42540CC2

P304

Q44954147-9CE67482-7973-4EE9-9D5F-7B5B71000F0B

P31

Q44954147-83CD03E2-EDAC-4B0B-AF2F-A8F09561B016

P356

Q44954147-A8F315BF-D5D1-4ABE-A846-5E87530678EB

P433

Q44954147-F0F30AC4-4017-43B7-B6BD-04FE13B69ED0

P478

Q44954147-5AE27C8C-5E19-44AC-B2FE-B6CE33DA0F5D

P50

Q44954147-5F44E02B-45DA-474B-85E4-3D63FE0E75BB

P577

Q44954147-78E78F51-147D-4898-ABD2-D52C0121514F

P5875

Q44954147-F8B7E538-DD6E-4D94-B6D0-CC5995E17F81

P698

Q44954147-039B0645-B751-467B-9E3B-34E0CB0285C9

P356

S00415-014-7444-2

P1433

Journal of Neurology

P1476

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

@en

P2093

Ada Francia

http://www.w3.org/2001/XMLSchema#string

Angelo Maurizio Clerici

http://www.w3.org/2001/XMLSchema#string

Anna Mazzeo

http://www.w3.org/2001/XMLSchema#string

Aristide Merola

http://www.w3.org/2001/XMLSchema#string

Dario Cocito

http://www.w3.org/2001/XMLSchema#string

Eduardo Nobile-Orazio

http://www.w3.org/2001/XMLSchema#string

Erdita Peci

http://www.w3.org/2001/XMLSchema#string

Gabriele Siciliano

http://www.w3.org/2001/XMLSchema#string

Giovanni Antonini

http://www.w3.org/2001/XMLSchema#string

Girolama Alessandra Marfia

http://www.w3.org/2001/XMLSchema#string

P2860

Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.

Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies.

A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.

Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

P2888

s00415-014-7444-2

P304

2159-2164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-014-7444-2

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

261

http://www.w3.org/2001/XMLSchema#string

P50

Leonardo Lopiano

P577

2014-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264990441

http://www.w3.org/2001/XMLSchema#string

P698

25149866

http://www.w3.org/2001/XMLSchema#string